Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Cardiol Young ; : 1-3, 2022 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-35657671

RESUMO

The association of truncus arteriosus communis with interrupted aortic arch and mitral atresia is an exceptionally rare congenital defect. We describe the initial decision-making and management of this lesion, which eventually achieved a Fontan palliation.

2.
Molecules ; 27(13)2022 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-35807411

RESUMO

The extraction of bioactive compounds from fruits, such as lemon, has gained relevance because these compounds have beneficial properties for health, such as antioxidant and anticancer properties; however, the extraction method can significantly affect these properties. High hydrostatic pressure and ultrasound, as emerging extraction methods, constitute an alternative to conventional extraction, improving extractability and obtaining extracts rich in bioactive compounds. Therefore, lemon extracts (LEs) were obtained by conventional (orbital shaking), ultrasound-assisted, and high-hydrostatic-pressure extraction. Extracts were then microencapsulated with maltodextrin at 10% (M10), 20% (M20), and 30% (M30). The impact of microencapsulation on LEs physicochemical properties, phenolics (TPC), flavonoids (TFC) and relative bio-accessibility (RB) was evaluated. M30 promoted a higher microencapsulation efficiency for TPC and TFC, and a longer time required for microcapsules to dissolve in water, as moisture content, water activity and hygroscopicity decreased. The RBs of TPC and TFC were higher in microcapsules with M30, and lower when conventional extraction was used. The data suggest that microencapsulated LE is promising as it protects the bioactivity of phenolic compounds. In addition, this freeze-dried product can be utilized as a functional ingredient for food or supplement formulations.


Assuntos
Fenóis , Extratos Vegetais , Antioxidantes/química , Antioxidantes/farmacologia , Cápsulas/química , Fenóis/química , Extratos Vegetais/química , Água
4.
Nat Commun ; 15(1): 4298, 2024 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-38769363

RESUMO

Earthquakes injure millions and simultaneously disrupt the infrastructure to protect them. This perspective argues that the current post-disaster investigation paradigm is insufficient to protect communities' health effectively. We propose the Earthquake Survival Chain as a framework to change the current engineering focus on infrastructure to health. This framework highlights four converging research opportunities to advance understanding of earthquake injuries, search and rescue, patient mobilizations, and medical treatment. We offer an interdisciplinary research agenda in engineering and health sciences, including artificial intelligence and virtual reality, to protect health and life from earthquakes.


Assuntos
Terremotos , Humanos , Engenharia , Planejamento em Desastres/métodos , Planejamento em Desastres/organização & administração , Desastres , Inteligência Artificial
5.
J Gastrointest Cancer ; 51(2): 571-578, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31407248

RESUMO

PURPOSE: In this work, we present a recently developed ruthenium complex that shows anticancer activity in gallbladder cancer cells. METHODS: After the synthesis of the new ruthenium complexes, the antiproliferative, cytotoxicity, and apoptosis activities were evaluated in vitro by the triple assay ApoTox-Glo. Then, the transcription levels of genes related to apoptosis were evaluated by real-time PCR (q-PCR). RESULTS: The ruthenium complex, called Ru-UCN3, inhibits the proliferation of gallbladder cancer cells G-415 by means of apoptosis, which was demonstrated by the overexpression of the pro-apoptotic genes Puma, Diablo, and Caspasa-9 together with the repression of the anti-apoptotic genes Bcl-xL and Bcl-2. In addition, we found strong caspase 3/7 activity in the cells at 24 h of the Ru-UCN3 exposure, which was evaluated by the triple ApoTox-Glo assay. CONCLUSION: The new ruthenium complexes evaluated had an inhibitory effect on G-415 cells. We think that Ru-UCN3 could be a promising anticancer agent, which should be explored with more in vitro and in vivo assays and probably with the chemical modulation of this molecule.


Assuntos
Morte Celular/efeitos dos fármacos , Neoplasias da Vesícula Biliar/tratamento farmacológico , Rutênio/química , Linhagem Celular Tumoral , Proliferação de Células , Humanos
6.
Med. crít. (Col. Mex. Med. Crít.) ; 37(2): 99-105, Feb. 2023. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1558396

RESUMO

Resumen: Introducción: la neumonía por coronavirus es emergente. Existen pocos datos del manejo ventilatorio. Presenta diferentes fenotipos pulmonares con difícil programación de la ventilación mecánica (VM). Se analizan estos pacientes en un hospital general. Material y métodos: se incluyen pacientes con neumonía por SARS-CoV-2 que ingresan a la unidad de cuidados intensivos (UCI) ventilados entre marzo y junio de 2020. Analizamos demografía, gravedad, programación ventilatoria, gases arteriales, mecánica pulmonar y desenlaces. Se describen los pacientes que recibieron posición prona (PP). Los pacientes se categorizaron por mediana de la compliance estática (Cst) y rangos ≤ 20, > 20 a ≤ 30 y > 30 en el día uno. Resultados: 118 pacientes, edad promedio 56.4 ± 1.3, 76.4% varones. El APACHE II y SOFA de ingreso: 13.6 ± 0.5 y 8.3 ± 0.2. Requirieron PP 47.5%. Los días de VM, UCI y hospital fueron 13.5 ± 0.9; 16.8 ± 0.9 y 23.8 ± 1.5. La mortalidad hospitalaria de pacientes PP y supinos fue de 32.1 y 11.3%, p = 0.005. Mortalidad global de 21.2%. Pacientes con Cst ≤ 20 mL/cmH2O presentaron una mortalidad de 44.4%. Conclusión: un porcentaje importante de los pacientes requiere PP precoz para superar la hipoxemia y aunque la mayoría responden, no asegura un buen desenlace hospitalario. Los pacientes con Cst ≤ 20 ml/cmH2O muestran mayor mortalidad.


Abstract: Introduction: coronavirus infection is an emerging pathology, there are few data regarding ventilatory management. Different pulmonary phenotypes make the MV process difficult. This encouraged us to analyze our COVID-19 patients with MV. Material and methods: all patients with SARS-CoV-2 pneumonia who were admitted ventilated to our unit through March to June 2020 were included. Demographics, severity scores, ventilatory settings, arterial gases, lung mechanics, and outcomes are analyzed. The patients who received prone position (PP) are described. Patients were categorized according to the median static compliance (Cst) and if it was ≤ 20, > 20 a ≤ 30 y > 30 in day 1. Results: 118 patients, the mean age was 56.4 ± 1.3, 76.4% males. APACHE II and SOFA on admission: 13.6 ± 0.5 and 8.3 ± 0.2. 47.5% of the patients required PP. The MV, ICU and hospital stay were 13.5 ± 0.9; 16.8 ± 0.9 and 23.8 ± 1.5 days. The in-hospital mortality of PP and supine patients was 32.1 and 11.3%, p = 0.005. Overall mortality 21.2%. Mortality of patients with Cst ≤ 20 mL/cmH2O was 44.4%. Conclusion: a significant percentage require early PP to overcome hypoxemia and although most respond, it does not ensure a good hospital outcome. The patients with compliance ≤ 20ml/ cmH2O have higher mortality.


Resumo: Introdução: a pneumonia por coronavírus é emergente. Existem poucos dados sobre o manejo ventilatório. Apresenta diferentes fenótipos pulmonares com difícil programação da VM. Esses pacientes são analisados em um hospital geral. Material e métodos: incluíram-se pacientes com pneumonia por SARS-CoV-2 internados na UTI ventilados entre março e junho de 2020. Analisamos dados demográficos, gravidade, programação ventilatória, gasometria arterial, mecânica pulmonar e desfechos. São descritos os pacientes que receberam posição prona (PP). Os pacientes foram categorizados pela média da compliance estática (Cst) e intervalos ≤ 20, >20 a ≤ 30 e >30 em 1 dia. Resultados: 118 pacientes, idade média 56.4 ± 1.3, 76.4% do sexo masculino. O APACHE II e SOFA de admissão: 13.6 ± 0.5 e 8.3 ± 0.2. Necessitaram PP 47.5%. Os dias de VM, UTI e hospital foram 13.5 ± 0.9; 16.8 ± 0.9 e 23.8 ± 1.5. A mortalidade hospitalar dos pacientes em PP e supino foi de 32.1 e 11.3%, p = 0.005. Mortalidade geral 21.2%. Pacientes com Cst ≤ 20 mL/cmH2O apresentaram mortalidade de 44.4%. Conclusão: muitos pacientes requerem PP precoce para superar a hipoxemia. A média da compliance não discrimina a mortalidade. Aqueles com Cst ≤ 20 apresentam maior mortalidade.

7.
Artigo em Inglês | MEDLINE | ID: mdl-25813163

RESUMO

A new ruthenium complex, [Ru(bpy)2(dbe-ppl)](PF6)2 (bpy=2,2'-bipyridine and dbe-ppl=dimethyl 4,4'-(pyrazino[2,3-f][1,10]phenanthroline-2,3-diyl)dibenzoate, has been synthesized and characterized by (1)H NMR spectroscopy, UV-Vis, IR, and cyclic voltammetry. Irradiation on the MLCT band results in photoluminescence in both protic and aprotic solvents. The photoluminescence in water is pH dependent, it shows a behavior which can be described by the Henderson-Hasselbalch assuming the protonation/deprotonation of the excited state with a pKa of 2.40±0.01.


Assuntos
Medições Luminescentes , Fenantrolinas/química , Rutênio/química , Concentração de Íons de Hidrogênio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA